Integrated Workflow for Drug Repurposing in Glioblastoma: Computational Prediction and Preclinical Validation of Therapeutic Candidates
Background: Glioblastoma (GBM) remains a significant challenge in oncology due to its resistance to standard treatments including temozolomide. This study aimed to develop and validate an integrated model for predicting GBM sensitivity to alternative chemotherapeutics and identifying new drugs and c...
Saved in:
Main Authors: | Nazareno Gonzalez, Melanie Pérez Küper, Matías Garcia Fallit, Jorge A. Peña Agudelo, Alejandro Nicola Candia, Maicol Suarez Velandia, Ana Clara Romero, Guillermo Videla Richardson, Marianela Candolfi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-06-01
|
Series: | Brain Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3425/15/6/637 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Repurposed Antipsychotics as Potential Anticancer Agents: Clozapine Efficacy and Dopaminergic Pathways in Neuroblastoma and Glioblastoma
by: Catarina Moura, et al.
Published: (2025-07-01) -
VARIANTS AND PERSPECTIVES OF DRUG REPURPOSING FOR CANCER TREATMENT
by: A. V. Savinkova, et al.
Published: (2018-07-01) -
COVID-19 and a Tale of Three Drugs: To Repurpose, or Not to Repurpose–That Was the Question
by: Chris R. Triggle, et al.
Published: (2025-06-01) -
Targeting iNAMPT and NAD Biosynthesis to Break the Obesity-Associated Liver Cancer Link
by: Kelly Thornton, et al.
Published: (2025-06-01) -
Translating Basic Science to Clinical Applications: A Narrative Review of Repurposed Pharmacological Agents in Preclinical Models of Diabetic Neuropathy
by: Corina Andrei, et al.
Published: (2025-07-01)